Daniel Faga

Insider Reports History

Entity
Individual
Location
3737 Market Street, Suite 1300, Philadelphia, PA
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Faga:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ANAPTYSBIO, INC CEO, Director Common Stock 160K $5.6M $35.00 Jul 22, 2024 Direct
ANAPTYSBIO, INC CEO, Director Restricted Stock Unit 53.6K $1.17M $21.81 Jan 6, 2024 Direct
ANAPTYSBIO, INC CEO, Director Stock Option (right to buy) 380K Jan 3, 2024 Direct

Insider Reports Filed by Daniel Faga

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANAB ANAPTYSBIO, INC Jul 22, 2024 1 $0 4 Jul 24, 2024 CEO, Director
ANAB ANAPTYSBIO, INC Mar 22, 2024 3 -$10.9M 4 Mar 26, 2024 CEO, Director
ANAB ANAPTYSBIO, INC Jan 6, 2024 3 -$150K 4 Jan 9, 2024 CEO, Director
ANAB ANAPTYSBIO, INC Jan 3, 2024 2 $0 4 Jan 5, 2024 CEO, Director
ANAB ANAPTYSBIO, INC Jan 6, 2023 2 $0 4 Jan 10, 2023 Interim CEO, Director
ANAB ANAPTYSBIO, INC Mar 21, 2022 1 $0 4 Mar 23, 2022 Interim CEO, Director
ANAB ANAPTYSBIO, INC Feb 10, 2022 1 $0 4 Feb 14, 2022 Director
ANAB ANAPTYSBIO, INC Nov 26, 2021 2 $0 4 Nov 30, 2021 Director
ANAB ANAPTYSBIO, INC Nov 26, 2021 0 $0 3 Nov 30, 2021 Director